Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel antiinflammatory agent from Parke-Davis

May 27, 1997

Fujisawa and Solvay sign marketing agreement for antidepressant

May 27, 1997

IDEC Pharmaceuticals: Q1 1997 highlights

May 27, 1997

PharmaSciences and BTG extend license for hydrogel drug delivery technology

May 27, 1997

Tamsulosin cleared by FDA

May 27, 1997

Protease inhibitors in Japan

May 27, 1997

Glaxo to submit NDA in Japan for lamivudine in hepatitis

May 27, 1997

MP-52 to be developed worldwide by HMR

May 27, 1997

NDA to be submitted in Japan for nevirapine

May 27, 1997

Prodrugs of nitrogen mustard with selective antitumor activity

May 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...